NCT00664352 is a Phase 1/Phase 2 clinical trial of Mannose-6-Phosphate (Juvidex) in Wound, sponsored by Renovo.

Who is sponsoring NCT00664352?

NCT00664352 is sponsored by Renovo.

What drugs are being tested in NCT00664352?

Interventions in NCT00664352: Mannose-6-Phosphate (Juvidex), Mannose-6-Phosphate (Juvidex), Mannose-6-Phosphate (Juvidex), Mannose-6-Phophate (Juvidex), Placebo.

Is NCT00664352 still recruiting?

NCT00664352 is currently completed. Last updated 5 January 2009.

Last reviewed 2009-01-05 · How we verify

NCT00664352

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Double Blind, Placebo Controlled Trial to Investigate the Efficacy and Safety of Two Concentrations of Juvidex (Mannose-6-Phosphate) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites Using Different Dosing Regimes

Completed Phase 1/Phase 2 Last updated 5 January 2009

What this trial tests

Phase 1/Phase 2 trial testing Mannose-6-Phosphate (Juvidex) in Wound in 195 participants. Completed in 1 November 2008.

Timeline

1 February 2008

Primary endpoint
1 October 2008

1 November 2008

Quick facts

Lead sponsor	Renovo
Phase	Phase 1/Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	195
Start date	1 February 2008
Primary completion	1 October 2008
Estimated completion	1 November 2008
Sites	1 location across United Kingdom

Drugs / interventions tested

Mannose-6-Phosphate (Juvidex) — full drug profile →
Mannose-6-Phosphate (Juvidex) — full drug profile →
Mannose-6-Phosphate (Juvidex) — full drug profile →
Mannose-6-Phophate (Juvidex) — full drug profile →
Placebo

Conditions studied

Wound — all drugs for Wound →

Sponsor

Renovo — full company profile →

Who can join

Adults 18 to 85, any sex, with Wound. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

The time to complete wound closure as assessed by the investigating physician
Time frame: Measured up to Day 28

Sponsor's own description

The objective of this study is to compare the efficacy of two concentrations of Juvidex with placebo on the healing of split thickness skin graft donor sites

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Wound

Currently open trials in the same condition.

NCT07398534 — PICO Negative Pressure for Uninfected Foot Ulcers and Wound Dehiscence (BALPIC) · NA · active not recruiting
NCT06957964 — Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds: A Randomized Clinical Trial · NA · recruiting
NCT06801626 — Novel Strategies for Reducing Burn Scar Itch · Phase 3 · recruiting
NCT06321978 — Mepilex Border Flex Utilization Pilot Spain · recruiting
NCT06138964 — Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00664352 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Renovo
Last refreshed: 5 January 2009

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00664352.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing